The Biopharmaceutics/Biologics research group led by Prof. Kungl of the Institute of Pharmaceutical Research recently participated in a highly productive EU Project Network meeting as part of the ongoing EU-funded B-ACTIVE project.
The B-ACTIVE network is dedicated to unraveling the highly complex regulation of the chemokine network, including chemokines, chemokine receptors, and extracellular matrix structures. This meeting provided an invaluable platform to present our initial findings and project plans while advancing the network’s shared objectives. Engaging discussions and interactive workshops highlighted the multidisciplinary nature of the collaboration, sparking innovative ideas and new approaches to address these challenges.
This visit underscores our institute’s commitment to international collaboration, driving innovation, and contributing to solutions with far-reaching impact.
The B-ACTIVE network, includes academic and industrial partners from Austria, Belgium, Denmark, Sweden, and Slovenia. The program receives funding from the European research and innovation program MARIE SKŁODOWSKA-CURIE ACTIONS Doctoral Networks – Horizon 2022. We look forward to continuing our work within this dynamic consortium also hosting future events to sustain the momentum of this exciting project.
For more information about the project, visit B-ACTIVE-dn.eu.